Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.58 ($0.02), with a volume of 953854 shares changing hands. The stock had previously closed at GBX 1.55 ($0.02).
Cizzle Biotechnology Trading Up 1.9 %
The firm has a market cap of £6.23 million, a P/E ratio of -2,204.86 and a beta of 0.38. The business has a 50-day moving average of GBX 1.72 and a two-hundred day moving average of GBX 1.84.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- Financial Services Stocks Investing
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Are Penny Stocks a Good Fit for Your Portfolio?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
